• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童复发性 B 细胞前体急性淋巴细胞白血病骨髓免疫环境的改变。

Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.

机构信息

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Laboratory of Human Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.

出版信息

Cancer Sci. 2022 Jan;113(1):41-52. doi: 10.1111/cas.15186. Epub 2021 Nov 29.

DOI:10.1111/cas.15186
PMID:34716967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8748249/
Abstract

Due to the considerable success of cancer immunotherapy for leukemia, the tumor immune environment has become a focus of intense research; however, there are few reports on the dynamics of the tumor immune environment in leukemia. Here, we analyzed the tumor immune environment in pediatric B cell precursor acute lymphoblastic leukemia by analyzing serial bone marrow samples from nine patients with primary and recurrent disease by mass cytometry using 39 immunophenotype markers, and transcriptome analysis. High-dimensional single-cell mass cytometry analysis elucidated a dynamic shift of T cells from naïve to effector subsets, and clarified that, during relapse, the tumor immune environment comprised a T helper 1-polarized immune profile, together with an increased number of effector regulatory T cells. These results were confirmed in a validation cohort using conventional flow cytometry. Furthermore, RNA transcriptome analysis identified the upregulation of immune-related pathways in B cell precursor acute lymphoblastic leukemia cells during relapse, suggesting interaction with the surrounding environment. In conclusion, a tumor immune environment characterized by a T helper 1-polarized immune profile, with an increased number of effector regulatory T cells, could contribute to the pathophysiology of recurrent B cell precursor acute lymphoblastic leukemia. This information could contribute to the development of effective immunotherapeutic approaches against B cell precursor acute lymphoblastic leukemia relapse.

摘要

由于癌症免疫疗法在白血病治疗方面取得了显著成功,肿瘤免疫微环境已成为研究的焦点;然而,关于白血病肿瘤免疫微环境的动态变化的研究报告却很少。在这里,我们通过对 9 例初诊和复发患者的骨髓样本进行高通量单细胞质量 cytometry 分析,使用 39 种免疫表型标志物和转录组分析,研究了儿童 B 细胞前体急性淋巴细胞白血病的肿瘤免疫微环境。高维单细胞质量 cytometry 分析阐明了 T 细胞从幼稚状态向效应亚群的动态转变,并阐明了在复发期间,肿瘤免疫微环境由 Th1 极化的免疫表型组成,同时效应调节性 T 细胞数量增加。这些结果在使用常规流式细胞术的验证队列中得到了证实。此外,RNA 转录组分析在复发期间鉴定出 B 细胞前体急性淋巴细胞白血病细胞中免疫相关途径的上调,提示与周围环境相互作用。总之,以 Th1 极化免疫表型为特征的肿瘤免疫微环境,伴有效应调节性 T 细胞数量增加,可能有助于复发性 B 细胞前体急性淋巴细胞白血病的病理生理学发生。这些信息可能有助于开发针对 B 细胞前体急性淋巴细胞白血病复发的有效免疫治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/c4fb238ea3a6/CAS-113-41-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/e6f5eea0362a/CAS-113-41-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/fdbc2a07b75d/CAS-113-41-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/336a6f22d112/CAS-113-41-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/d1427c4795bf/CAS-113-41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/c7fc71395f66/CAS-113-41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/c4fb238ea3a6/CAS-113-41-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/e6f5eea0362a/CAS-113-41-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/fdbc2a07b75d/CAS-113-41-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/336a6f22d112/CAS-113-41-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/d1427c4795bf/CAS-113-41-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/c7fc71395f66/CAS-113-41-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c556/8748249/c4fb238ea3a6/CAS-113-41-g006.jpg

相似文献

1
Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.儿童复发性 B 细胞前体急性淋巴细胞白血病骨髓免疫环境的改变。
Cancer Sci. 2022 Jan;113(1):41-52. doi: 10.1111/cas.15186. Epub 2021 Nov 29.
2
Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.单细胞转录组分析儿科急性白血病的免疫微环境。
Cancer Lett. 2024 Aug 1;596:217018. doi: 10.1016/j.canlet.2024.217018. Epub 2024 Jun 4.
3
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.采用八色流式细胞术对复发性儿童急性淋巴细胞白血病进行微小残留病分析。
Haematologica. 2015 Jul;100(7):935-44. doi: 10.3324/haematol.2014.116707. Epub 2015 May 22.
4
Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.B 细胞急性淋巴细胞白血病中免疫微环境的广泛重塑。
Cancer Cell. 2020 Jun 8;37(6):867-882.e12. doi: 10.1016/j.ccell.2020.04.015. Epub 2020 May 28.
5
Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients.骨髓辅助性 T 细胞具有 Th1 表型,可诱导前体 B 急性淋巴细胞白血病患者白血病细胞的激活和增殖。
Oncogene. 2019 Mar;38(13):2420-2431. doi: 10.1038/s41388-018-0594-4. Epub 2018 Dec 7.
6
Risk-associated alterations in marrow T cells in pediatric leukemia.儿童白血病骨髓 T 细胞的风险相关改变。
JCI Insight. 2020 Aug 20;5(16):140179. doi: 10.1172/jci.insight.140179.
7
Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.骨髓再生样本中 B 细胞前体细胞的免疫表型转变:B 淋巴细胞白血病微小残留病评估的关键考虑因素。
Cytometry B Clin Cytom. 2021 Jul;100(4):434-445. doi: 10.1002/cyto.b.21951. Epub 2020 Sep 8.
8
A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia.CAR T 细胞治疗儿童 B 细胞急性淋巴细胞白血病期间骨髓动力学的数学描述。
Int J Mol Sci. 2021 Jun 14;22(12):6371. doi: 10.3390/ijms22126371.
9
Increased expression of immune checkpoint programmed cell death protein-1 (PD-1) on T cell subsets of bone marrow aspirates in patients with B-Lymphoblastic leukemia, especially in relapse and at diagnosis.骨髓抽吸物中 T 细胞亚群中免疫检查点程序性细胞死亡蛋白 1(PD-1)表达增加,尤其是在复发和诊断时患有 B 淋巴细胞白血病的患者中。
Cytometry B Clin Cytom. 2020 Jul;98(4):336-347. doi: 10.1002/cyto.b.21879. Epub 2020 Apr 8.
10
Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.CD25的表达是儿童B系急性淋巴细胞白血病中费城染色体(BCR-ABL1)易位的一种特异性且相对敏感的标志物。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6225-30. eCollection 2014.

引用本文的文献

1
Unlocking the Complexity: Exploration of Acute Lymphoblastic Leukemia at the Single Cell Level.解锁复杂性:单细胞水平探索急性淋巴细胞白血病。
Mol Diagn Ther. 2024 Nov;28(6):727-744. doi: 10.1007/s40291-024-00739-5. Epub 2024 Aug 27.
2
Significance of Th17 and Treg in Treatment Efficacy and Outcome in Pediatric Acute Lymphoblastic Leukemia.Th17 和 Treg 在儿童急性淋巴细胞白血病治疗疗效和预后中的意义。
Int J Mol Sci. 2023 Aug 1;24(15):12323. doi: 10.3390/ijms241512323.
3
IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia.

本文引用的文献

1
Immunogenomic Landscape of Hematological Malignancies.血液系统恶性肿瘤的免疫基因组全景
Cancer Cell. 2020 Sep 14;38(3):380-399.e13. doi: 10.1016/j.ccell.2020.06.002. Epub 2020 Jul 9.
2
Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.激活的不变自然杀伤 T 细胞以 CD1d 非依赖性的方式直接识别白血病细胞。
Cancer Sci. 2020 Jul;111(7):2223-2233. doi: 10.1111/cas.14428. Epub 2020 Jun 19.
3
Acute lymphoblastic leukaemia.急性淋巴细胞白血病。
白细胞介素-10 rs1800896多态性:成人急性淋巴细胞白血病的一个风险因素。
Pharmgenomics Pers Med. 2022 Sep 12;15:809-815. doi: 10.2147/PGPM.S377356. eCollection 2022.
Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1.
4
Leukemia-induced dysfunctional TIM-3CD4 bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients.白血病导致的 TIM-3CD4 骨髓 T 细胞功能障碍增加了儿童 B 前体 ALL 患者复发的风险。
Leukemia. 2020 Oct;34(10):2607-2620. doi: 10.1038/s41375-020-0793-1. Epub 2020 Mar 13.
5
Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials.用于免疫研究和人类癌症临床试验监测的质谱流式细胞术相对于流式细胞术的验证
Front Oncol. 2019 May 17;9:415. doi: 10.3389/fonc.2019.00415. eCollection 2019.
6
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?肿瘤微环境中的调节性 T 细胞(Treg 细胞):Treg 细胞能否成为新的治疗靶点?
Cancer Sci. 2019 Jul;110(7):2080-2089. doi: 10.1111/cas.14069. Epub 2019 Jun 18.
7
diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering.diffcyt:通过高分辨率聚类进行高维流式细胞术的差异发现。
Commun Biol. 2019 May 14;2:183. doi: 10.1038/s42003-019-0415-5. eCollection 2019.
8
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.趋化因子调节肿瘤发生、转移和免疫治疗反应中的免疫监视。
Front Immunol. 2019 Feb 27;10:333. doi: 10.3389/fimmu.2019.00333. eCollection 2019.
9
Human FOXP3 Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.人类 FOXP3 调节性 T 细胞在自身免疫和癌症中的异质性和功能。
Immunity. 2019 Feb 19;50(2):302-316. doi: 10.1016/j.immuni.2019.01.020.
10
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL.骨髓微环境中的免疫细胞构成可预测成人 ALL 的预后。
Leukemia. 2019 Jul;33(7):1570-1582. doi: 10.1038/s41375-018-0360-1. Epub 2019 Jan 11.